Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
2.215
-0.015 (-0.67%)
At close: Dec 5, 2025, 4:00 PM EST
2.130
-0.085 (-3.84%)
After-hours: Dec 5, 2025, 5:21 PM EST
Repare Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Repare Therapeutics stock have an average target of 3.50, with a low estimate of 3.00 and a high estimate of 4.00. The average target predicts an increase of 58.01% from the current stock price of 2.22.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 27, 2025.
Analyst Ratings
The average analyst rating for Repare Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +35.44% | Oct 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $5 | Strong Buy | Maintains | $10 → $5 | +125.73% | Mar 7, 2025 |
| LifeSci Capital | LifeSci Capital | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 13, 2024 |
| Stifel | Stifel | Strong Buy Maintains $9 → $4 | Strong Buy | Maintains | $9 → $4 | +80.59% | Dec 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +351.47% | Nov 8, 2024 |
Financial Forecast
Revenue This Year
6.21M
from 53.48M
Decreased by -88.39%
Revenue Next Year
6.80M
from 6.21M
Increased by 9.55%
EPS This Year
-1.75
from -2.00
EPS Next Year
-0.74
from -1.75
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 12.5M | 21.0M | ||||
| Avg | 6.2M | 6.8M | ||||
| Low | 294,000 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -76.7% | 238.3% | ||||
| Avg | -88.4% | 9.6% | ||||
| Low | -99.5% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.40 | -0.77 | |
| Avg | -1.75 | -0.74 | |
| Low | -2.07 | -0.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.